Mainland China
Hisense Unveils "Innovating a Brighter Life" at CES 2026
LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, today hosted its CES 2026 press conference under the theme "Innovating aBrighter Life," showcasing its latest advances in display technology and smart home products—focused on more...
2026-01-06 05:39
6075
CreateAI Announces Results of 2025 Annual Meeting of Stockholders
SAN DIEGO and BEIJING, Jan. 5, 2026 /PRNewswire/ -- CreateAI Holdings Inc. (OTCMKTS: TSPH) ("CreateAI" or the "Company"), a global leader in applied artificial intelligence, today announced shareholder voting results for its annual meeting of stockholders held onDecember 29, 2025 (the "Annual Mee...
2026-01-06 05:30
605
Nanjing Delova Announces Statistically Significant and Clinically Meaningful Results From Two Phase 3 Trials of QP-6211 for the Treatment of Postoperative Pain
* Treatment with QP-6211 achieved primary and all key secondary endpoints in both placebo- and active-controlled Phase 3 trials following hemorrhoidectomy or bunionectomy. * QP-6211 demonstrated statistically significant reductions in postoperative pain and opioid consumption through 72 hou...
2026-01-05 23:00
2672
TEYU Chillers Scale Up with Quality: 230,000 Units Delivered Annually, Powering Reliable Global Industrial Cooling
GUANGZHOU, China, Jan. 5, 2026 /PRNewswire/ -- TEYU, a long-established supplier of global industrial laser cooling solutions, has achieved a new production milestone: the company now delivers 230,000 chillers annually. Backed byan annual production capacity of 300,000 units, this milestone demo...
2026-01-05 21:16
2798
SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson's disease
SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment SHANGHAI, ATLANTA and NEW HAVEN, Conn. , Jan. 5, 2026 /PRNewswire/ -- SynuSight Biotech ("SynuSight"), a biotechnology company...
2026-01-05 21:05
1380
COCOS 4 Is Here, Fully Open Source
BEIJING, Jan. 5, 2026 /PRNewswire/ -- COCOS, the globally renowned provider of
game engines and development tools fully acquired by SUD, today announced the
full open-sourcing of COCOS 4.
2026-01-05 20:33
4108
NaaS Technology Inc. to Hold Extraordinary General Meeting on January 23, 2026
BEIJING, Jan. 5, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that it will hold an extraordinary general meeting of shareholders (the "EGM") at03:00 PM Beijing time on January 23, 202...
2026-01-05 20:00
2010
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally developed integrin beta-6 (ITGB6)-targeted ant...
2026-01-05 20:00
6714
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the"Group"), a global wellness group off...
2026-01-05 17:36
4278
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) in combination wi...
2026-01-05 17:29
8445
Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up
HAIKOU, China, Jan. 5, 2026 /PRNewswire/ -- A news report from Haikou Municipal Bureau of Tourism, Culture, Radio, Television and Sports: As a key hub of the Hainan Free Trade Port, Haikou is advancing its opening-up and global engagement through major international events, including the 2025 Ch...
2026-01-05 14:21
3447
Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up
HAIKOU, China, Jan. 5, 2026 /PRNewswire/ -- A news report from Haikou Municipal Bureau of Tourism, Culture, Radio, Television and Sports: As a key hub of the Hainan Free Trade Port, Haikou is accelerating its opening-up and global engagement through a series of major international events, includ...
2026-01-05 13:17
2747
GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application...
2026-01-05 12:07
6566
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
WUXI, China, Jan. 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrates sustainability principles into procurement practices and promotes transparency and responsibility ac...
2026-01-05 11:57
3041
COCOS 4 Is Here, Fully Open Source
BEIJING, Jan. 4, 2026 /PRNewswire/ -- COCOS, the globally renowned provider of game engines and development tools fully acquired by SUD, today announced the full open-sourcing of COCOS 4. Scope of Open Source The following repositories are now publicly available: 1. Engine Repository: https:/...
2026-01-05 10:00
2711
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 in participants with diabetes. Enrollment is expected to begin in the first quarter of 2026. -ASC30 demonstrated placebo-...
2026-01-05 08:10
6505
Visualize Heat Loss in Minutes: Raytron Brings Thermal Imaging to Building Energy Audits
YANTAI, China, Jan. 4, 2026 /PRNewswire/ -- As colder months set in, building heat loss becomes more costly. With buildings' operational energy use representing about 30% of global final energy consumption (IEA), Raytron's infrared thermal imaging solutions enable energy auditors to identify buil...
2026-01-04 23:30
407
iFLYTEK to Showcase Real-World AI Voice and Translation Technologies at Pepcom 2026 in Las Vegas
LAS VEGAS, Jan. 4, 2026 /PRNewswire/ -- iFLYTEK Co., Ltd., a global Artificial Intelligence company specializing in speech and language technologies, announced its participation inPepcom Digital Experience! during CES 2026, taking place inLas Vegas. During the event, members of the media will hav...
2026-01-04 22:00
458
RayNeo Unveils World's First eSIM-Enabled AR Glasses for CES 2026
LAS VEGAS, Jan. 4, 2026 /PRNewswire/ -- RayNeo, a leading global consumer-grade AR brand, today announced it has secured a new round of funding. The investment was joined by Unicom Innovation Capital, a subsidiary of China Unicom, and the investment arms of China Mobile (CM Beijing Fund and CM Sh...
2026-01-04 22:00
1811
Baseus Powers Up CES 2026 with Full-Range Innovations
SHENZHEN, China, Jan. 4, 2026 /PRNewswire/ -- Baseus, a user-centric consumer technology brand, will present an elevated presence and a new wave of innovation at CES 2026, driving forward inMobile Digital, Smart Audio, and Smart Securityand setting its sights on becoming the next-generation leade...
2026-01-04 22:00
2310
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 326 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 301 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09
Most Read
/C O R R E C T I O N -- Republic Power Group Limited (NASDAQ: RPGL)/
2026-02-20 06:36
8004